Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 4,041 $ 2,906
Prepaid expenses and other current assets 1,706 1,643
Total current assets 5,747 4,549
Property and equipment, net 53 68
Restricted cash 101 101
Other assets 129
Total assets 6,030 4,718
Current liabilities:    
Accounts payable 3,472 4,072
Accrued expenses 1,387 736
Term loans payable 8,776 3,016
Total current liabilities 13,635 7,824
Notes payable to vendors 1,264 1,273
Total liabilities 14,899 9,097
Stockholders' deficit:    
Common stock, $0.001 par value: 85,000,000 shares authorized at March 31, 2017 and December 31, 2016; 14,977,397 shares issued and outstanding at March 31, 2017 and December 31, 2016 15 15
Additional paid-in capital 237,274 236,216
Accumulated deficit (246,158) (240,610)
Total stockholders' deficit (8,869) (4,379)
Total liabilities and stockholders' deficit $ 6,030 $ 4,718